FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Fibrelief 3.5g granules sachets (Manx Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lacri-lube eye ointment (Allergan Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment (CST Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lacrilube eye ointment preservative free (AbbVie Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lacri-lube eye ointment (Allergan Ltd) 5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
YourFIBRE High-Fibre 3.5g granules sachets (Your Products Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Lacrilube eye ointment preservative free 5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free sugar free 10 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Lacrilube eye ointment preservative free 3.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Accord Healthcare Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
YourFIBRE High-Fibre 3.5g granules sachets (Your Products Ltd) 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lacri-lube eye ointment (Allergan Ltd) 3.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fibrelief 3.5g granules sachets (Manx Healthcare Ltd) 10 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lacrilube eye ointment preservative free (AbbVie Ltd) 3.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Accord Healthcare Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Aciclovir 3% eye ointment (CST Pharma Ltd) 4.5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ispaghula husk 3.5g granules sachets gluten free sugar free 30 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Piqray 50mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Piqray 50mg tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Accord Healthcare Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Alpelisib 50mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment (Alliance Healthcare (Distribution) Ltd) 120 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1mg/10ml solution for injection pre-filled syringes 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1mg/10ml solution for injection pre-filled syringes (Accord Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Minijet atropine 1mg/10ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1mg/10ml solution for injection pre-filled syringes (Accord Healthcare Ltd) 1 pre-filled disposable injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Minijet atropine 1mg/10ml solution for injection pre-filled syringes (Celltech Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Colestyramine 4g oral powder sachets 50 sachet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Water_for injections 500ml bottles 10 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Water_for injections 500ml bottles 1 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Water_for injections 500ml bottles (Alliance Healthcare (Distribution) Ltd) 1 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Water_for injections 500ml bottles (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Melatonin 2mg modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Water_for injections 500ml bottles (B.Braun Medical Ltd) 10 bottle VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Water_for injections 500ml bottles (B.Braun Medical Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Levofloxacin 5mg/ml eye drops 0.5ml unit dose preservative free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levofloxacin 5mg/ml eye drops 0.5ml unit dose preservative free 20 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oftaquix 5mg/ml eye drops 0.5ml unit dose (Santen) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxalux 5mg/ml eye drops 0.5ml unit dose (Kestrel Ophthalmics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxalux 5mg/ml eye drops 0.5ml unit dose (Kestrel Ophthalmics Ltd) 20 unit dose 4 x 5 unit doses VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oftaquix 5mg/ml eye drops 0.5ml unit dose (Santen) 30 unit dose 3 x 10 unit doses VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levofloxacin 5mg/ml eye drops 0.5ml unit dose preservative free 30 unit dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocolloid dressing semi-permeable sterile with adhesive border 15cm x 18cm sacral VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Bemiparin sodium 2,500units/0.2ml solution for injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bemiparin sodium 3,500units/0.2ml solution for injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 500mg/50ml solution for injection vials (Teva UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Colistimethate 1,662,500unit inhalation powder capsules 56 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 500mg/50ml solution for infusion vials (Consilient Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 500mg/50ml solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 500mg/50ml solution for injection vials (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (Pilsco Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (Pilsco Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Colobreathe 1,662,500unit inhalation powder capsules (Forest Laboratories UK Ltd) 56 capsule 4 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 500mg/50ml solution for infusion vials (Consilient Health Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Colobreathe 1,662,500unit inhalation powder capsules (Forest Laboratories UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocolloid dressing semi-permeable sterile with adhesive border 14cm x 14cm square VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitocin 20mg powder and solvent for intravesical solution vials (Vygoris Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitocin 20mg powder and solvent for intravesical solution vials (Vygoris Ltd) 5 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials (medac UK) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials (medac UK) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials 5 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Mitocin 20mg powder and solvent for intravesical solution vials (Vygoris Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (DE Pharmaceuticals) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (DE Pharmaceuticals) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydroxycarbamide 100mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent (pH10.5) for solution for infusion vials VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent for solution for injection vials (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Siklos 100mg tablets (Masters Pharmaceuticals Ltd) 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Siklos 100mg tablets (Masters Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Thiopental 500mg powder for solution for injection vials (Advanz Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent for solution for infusion vials (Sandoz Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flolan 500microgram powder and solvent for solution for injection vials (GlaxoSmithKline) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 50micrograms/hour transdermal patches (CST Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent for solution for infusion vials (Sandoz Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
MagnEss Gly 121.25mg/5ml (5mmol/5ml) oral solution (Essential-Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent for solution for infusion vials (Sandoz Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
MagnEss Gly 121.25mg/5ml (5mmol/5ml) oral solution (Essential-Healthcare Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 75micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent for solution for injection vials (GlaxoSmithKline) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol sodium 1.5mg powder and solvent for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol sodium 500microgram powder and solvent for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent for solution for infusion vials (Sandoz Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flolan 500microgram powder and solvent for solution for injection vials (GlaxoSmithKline) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Durogesic DTrans 25micrograms/hour transdermal patches (CST Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 8 of 86 Next End

This concept is not in any reference sets

Back to Start